Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Statera Biopharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 35 | 0 |
| Shares | 3.16M | 2.97M | −188.5K (−6.0%) |
| Value | $894.9K | $383.3K | −$511.6K (−57.2%) |
New holders (2)
Institutions that held Statera Biopharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 102,385 | $13.0K | 0.00% |
| Royal Bank of Canada | 9 | $0 | 0.00% |
Sold out (2)
Institutions that held Statera Biopharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Jane Street Group, LLC | 35,422 | $10.0K |
| Beacon Pointe Advisors, LLC | 18,494 | $5.00K |